Belinda L Lartey1, Susan Damanka1, Francis Ekow Dennis1, Christabel C Enweronu-Laryea2, Emmanuel Addo-Yobo3, Daniel Ansong3, Sandra Kwarteng-Owusu3, Kwamena W Sagoe4, Jason M Mwenda5, Stanley K Diamenu6, Clement Narh7, Fred Binka7, Umesh Parashar8, Ben Lopman9, George E Armah10. 1. Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. 2. School of Medicine and Dentistry, University of Ghana, Ghana. 3. School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 4. School of Biomedical and Allied Health Sciences, University of Ghana, Ghana. 5. World Health Organization (WHO) Regional Office for Africa (WHO/AFRO), Brazzaville, Congo. 6. WHO Country Office, Accra, Ghana. 7. School of Public Health, University of Health and Allied Sciences, Ho, Ghana. 8. Centers for Disease Control and Prevention, Atlanta, GA, USA. 9. Dept. of Epidemiology, Rollins School of Public Health, Emory University, USA. 10. Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. Electronic address: garmah@noguchi.ug.edu.gh.
Abstract
BACKGROUND: Ghana introduced the monovalent rotavirus vaccine (Rotarix) into its national paediatric vaccination programme in May2012. Vaccine introduction was initiated nationwide and achieved >85% coverage within a few months. Rotavirus strain distribution pre- and post-RV vaccine introduction is reported. METHODS: Stool samples were collected from diarrhoeic children <5 years of age hospitalized between 2009 and 2016 at sentinel sites across Ghana and analyzed for the presence of group A rotavirus by enzyme immunoassay. Rotavirus strains were characterized by RT-PCR and sequencing. RESULTS: A total of 1363 rotavirus EIA-positive samples were subjected to molecular characterization. These were made up of 823 (60.4%) and 540 (39.6%) samples from the pre- and post-vaccine periods respectively. Rotavirus VP7 genotypes G1, G2 and G3, and VP4 genotypes P[6] and P[8] constituted more than 65% of circulating G and P types in the pre-vaccine period. The common strains detected were G1P[8] (20%), G3P[6] (9.2%) and G2P[6] (4.9%). During the post-vaccine period, G12, G1 and G10 genotypes, constituted more than 65% of the VP7 genotypes whilst P[6] and P[8] made up more than 75% of the VP4 genotypes. The predominant circulating strains were G12P[8] (26%), G10P[6] (10%) G3P[6] (8.1%) and G1P[8] (8.0%). We also observed the emergence of the unusual rotavirus strain G9P[4] during this period. CONCLUSION: Rotavirus G1P[8], the major strain in circulation during the pre-vaccination era, was replaced by G12P[8] as the most predominant strain after vaccine introduction. This strain replacement could be temporary and unrelated to vaccine introduction since an increase in G12 was observed in countries yet to introduce the rotavirus vaccine in West Africa. A continuous surveillance programme in the post-vaccine era is necessary for the monitoring of circulating rotavirus strains and the detection of unusual/emerging genotypes.
BACKGROUND: Ghana introduced the monovalent rotavirus vaccine (Rotarix) into its national paediatric vaccination programme in May2012. Vaccine introduction was initiated nationwide and achieved >85% coverage within a few months. Rotavirus strain distribution pre- and post-RV vaccine introduction is reported. METHODS: Stool samples were collected from diarrhoeic children <5 years of age hospitalized between 2009 and 2016 at sentinel sites across Ghana and analyzed for the presence of group A rotavirus by enzyme immunoassay. Rotavirus strains were characterized by RT-PCR and sequencing. RESULTS: A total of 1363 rotavirus EIA-positive samples were subjected to molecular characterization. These were made up of 823 (60.4%) and 540 (39.6%) samples from the pre- and post-vaccine periods respectively. Rotavirus VP7 genotypes G1, G2 and G3, and VP4 genotypes P[6] and P[8] constituted more than 65% of circulating G and P types in the pre-vaccine period. The common strains detected were G1P[8] (20%), G3P[6] (9.2%) and G2P[6] (4.9%). During the post-vaccine period, G12, G1 and G10 genotypes, constituted more than 65% of the VP7 genotypes whilst P[6] and P[8] made up more than 75% of the VP4 genotypes. The predominant circulating strains were G12P[8] (26%), G10P[6] (10%) G3P[6] (8.1%) and G1P[8] (8.0%). We also observed the emergence of the unusual rotavirus strain G9P[4] during this period. CONCLUSION: Rotavirus G1P[8], the major strain in circulation during the pre-vaccination era, was replaced by G12P[8] as the most predominant strain after vaccine introduction. This strain replacement could be temporary and unrelated to vaccine introduction since an increase in G12 was observed in countries yet to introduce the rotavirus vaccine in West Africa. A continuous surveillance programme in the post-vaccine era is necessary for the monitoring of circulating rotavirus strains and the detection of unusual/emerging genotypes.
Authors: Waled M El-Senousy; Amel S M Abu Senna; Nabil A Mohsen; Seham F Hasan; Nagwa M Sidkey Journal: Food Environ Virol Date: 2020-04-11 Impact factor: 2.778
Authors: Betty E Owor; Mike J Mwanga; Regina Njeru; Robert Mugo; Mwanajuma Ngama; Grieven P Otieno; D J Nokes; C N Agoti Journal: Wellcome Open Res Date: 2019-05-15
Authors: Eva D João; Benilde Munlela; Assucênio Chissaque; Jorfélia Chilaúle; Jerónimo Langa; Orvalho Augusto; Simone S Boene; Elda Anapakala; Júlia Sambo; Esperança Guimarães; Diocreciano Bero; Marta Cassocera; Idalécia Cossa-Moiane; Jason M Mwenda; Isabel Maurício; Hester G O'Neill; Nilsa de Deus Journal: Pathogens Date: 2020-08-19
Authors: Sebotsana Rasebotsa; Jeannine Uwimana; Milton T Mogotsi; Kebareng Rakau; Nonkululeko B Magagula; Mapaseka L Seheri; Jason M Mwenda; M Jeffrey Mphahlele; Saheed Sabiu; Richard Mihigo; Leon Mutesa; Martin M Nyaga Journal: Viruses Date: 2021-01-12 Impact factor: 5.048